Our first ever Scientific Sessions took place in 1941 and featured just 250 attendees. Our last in-person Scientific Sessions hosted more than 15,000 attendees from around the world. There, among dozens of other exciting study results, the Teplizumab Prevention Trial, supported by TrialNet, showed that a medication could delay type 1 diabetes by an average of two years.
|